Literature DB >> 16828847

The value of preoperative platelet count in the prediction of cervical involvement and poor prognostic variables in patients with endometrial carcinoma.

Ali Ayhan1, Gurkan Bozdag, Cagatay Taskiran, Murat Gultekin, Kunter Yuce, Turkan Kucukali.   

Abstract

OBJECTIVE(S): To evaluate the relationship between preoperative platelet counts and prognostic factors extensively, among endometrial cancer patients, especially with respect to cervical involvement.
METHODS: One-hundred fifty-five patients with endometrial carcinoma, who underwent surgery as the initial treatment consisting peritoneal cytology, total abdominal hysterectomy, bilateral salpingo-oophorectomy, systematic pelvic-paraaortic lymphadenectomy, and omentectomy were retrospectively analyzed.
RESULTS: There were no differences with respect to age, histological type (endometrioid vs. non-endometrioid), depth of myometrial invasion, peritoneal cytology, LVSI, and lymphatic metastasis. However, advanced stage (stages III and IV), poorly differentiated tumor grade (grade 3), the presence of cervical and adnexal involvements were associated with significantly higher median preoperative platelet counts. Accepting 325.000/microl platelet count as a threshold value, multivariate analysis revealed cervical involvement (P=0.008; OR=1.84, 95% CI:1.17-2.89) and presence of high grade histology (P=0.014; OR=2.23, 95% CI:1.18-4.23, for grade 3 disease) to be significantly associated with higher platelet count. At a cut-off value of 326.000/microl, 42.3% sensitivity and 82.8% specificity for the prediction of cervical involvement was observed under receiver operator characteristic curve method. CONCLUSION(S): Higher preoperative platelet counts, even in conditions with normal range (150.000-400.000/microl), may reflect poor prognostic factors such as cervical involvement and high grade among patients with endometrial carcinoma. Also, the higher platelet count should be taken into consideration for the necessity of radical hysterectomy.

Entities:  

Mesh:

Year:  2006        PMID: 16828847     DOI: 10.1016/j.ygyno.2006.05.034

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  14 in total

1.  A humanized single-chain antibody against beta 3 integrin inhibits pulmonary metastasis by preferentially fragmenting activated platelets in the tumor microenvironment.

Authors:  Wei Zhang; Suying Dang; Tao Hong; Jian Tang; Jing Fan; Dawei Bu; Yanjie Sun; Zhugang Wang; Thomas Wisniewski
Journal:  Blood       Date:  2012-08-09       Impact factor: 22.113

2.  Prediction of staging with preoperative parameters and frozen/section in patients with a preoperative diagnosis of grade 1 endometrioid tumor in endometrial cancer.

Authors:  Alper Karalok; Işın Ureyen; Yıldız Reis; Ozge Oktay; Taner Turan; Nurettin Boran; Dilek Bülbül; Gökhan Tulunay; Mehmet Faruk Köse
Journal:  J Turk Ger Gynecol Assoc       Date:  2014-01-30

Review 3.  Contribution of platelets to tumour metastasis.

Authors:  Laurie J Gay; Brunhilde Felding-Habermann
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

4.  Chemotherapy Response Rates Among Patients With Endometrial Cancer Who Have Elevated Serum Platelets.

Authors:  Nora T Kizer; Hatem Hatem; Elizabeth K Nugent; Gongfu Zhou; Kathleen Moore; Paul Heller; David G Mutch; Premal H Thaker
Journal:  Int J Gynecol Cancer       Date:  2015-07       Impact factor: 3.437

Review 5.  Deadly allies: the fatal interplay between platelets and metastasizing cancer cells.

Authors:  Luise Erpenbeck; Michael P Schön
Journal:  Blood       Date:  2010-03-01       Impact factor: 22.113

6.  Relation of Preoperative Thrombocytosis between Tumor Stage and Grade in Patients with Endometrial Cancer.

Authors:  Songul Kaloglu; Hakan Guraslan; Ali Ismet Tekirdag; Hediye Dagdeviren; Cihan Kaya
Journal:  Eurasian J Med       Date:  2014-08-26

7.  Preoperative hemoglobin and platelet count and poor prognostic factors in patients with endometrial carcinoma.

Authors:  Jale Metindir; Gülay Bilir Dilek
Journal:  J Cancer Res Clin Oncol       Date:  2008-06-10       Impact factor: 4.553

8.  Sex Differences in Using Systemic Inflammatory Markers to Prognosticate Patients with Head and Neck Squamous Cell Carcinoma.

Authors:  Ching Ying Lin; Hyunwoo Kwon; Guillermo O Rangel Rivera; Xue Li; Dongjun Chung; Zihai Li
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-07-26       Impact factor: 4.254

9.  Neutrophil-lymphocyte and platelet-lymphocyte ratios in endometrial hyperplasia.

Authors:  Bulent Cakmak; Selim Gulucu; Nurlan Aliyev; Zeki Ozsoy; Mehmet Nacar; Dogan Koseoglu
Journal:  Obstet Gynecol Sci       Date:  2015-03-16

10.  Angiogenesis and lymphangiogenesis as prognostic factors after therapy in patients with cervical cancer.

Authors:  Marta Biedka; Roman Makarewicz; Ewa Kopczyńska; Andrzej Marszałek; Alina Goralewska; Hanna Kardymowicz
Journal:  Contemp Oncol (Pozn)       Date:  2012-02-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.